Artwork

Content provided by Greater Winston-Salem. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Greater Winston-Salem or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 021: Plakous Therapeutics

 
Share
 

Manage episode 363953901 series 3477975
Content provided by Greater Winston-Salem. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Greater Winston-Salem or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Plakous Therapeutics, a biotech start-up in Winston-Salem, is pioneering regenerative healing from traditional stem cell therapies. Using proteins from the human placenta, the company is developing medicine to combat necrotizing enterocolitis, also known as NEC. NEC is a condition that affects premature babies weighing less than three pounds and between 22 to 33 weeks of age. Rob Boyce, CEO of Plakous Therapeutics, joins us to discuss product development and his career path from naval aviation and marketing to biotech.
  continue reading

71 episodes

Artwork
iconShare
 
Manage episode 363953901 series 3477975
Content provided by Greater Winston-Salem. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Greater Winston-Salem or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Plakous Therapeutics, a biotech start-up in Winston-Salem, is pioneering regenerative healing from traditional stem cell therapies. Using proteins from the human placenta, the company is developing medicine to combat necrotizing enterocolitis, also known as NEC. NEC is a condition that affects premature babies weighing less than three pounds and between 22 to 33 weeks of age. Rob Boyce, CEO of Plakous Therapeutics, joins us to discuss product development and his career path from naval aviation and marketing to biotech.
  continue reading

71 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide